Cationic liposomes loaded with tumor-specific synthetic long peptides (SLPs) and TLR3 ligands as adjuvants could also induce cytotoxicity against target cells in vivo by strongly activating functional antigen-specific CD4+ T cells and CD8+ T cells [117]. The gene discussed is TLR3; the disease is neoplasm.